In 2025, the sector in Bahrain amounted to USD 262.5 million.
The Bahrain Infusion Services Market to reach USD 619.4 million by 2033, showing an anticipated CAGR of 11.3% over the forecast horizon.
Compact public healthcare infrastructure sustains biologic infusion access with limited volatility in systemic therapy volumes.
Bahrain National Health Regulatory Authority publications confirm continued oncology service delivery within public hospital networks.
DataCube Research Report (Feb 2026): This analysis uses 2024 as the actual year, 2025 as the estimated year, and calculates CAGR for the 2025-2033 period.
*Research Methodology: This report is based on DataCube’s proprietary 3-stage forecasting model, combining primary research, secondary data triangulation, and expert validation.
[Learn more]